Patents by Inventor JERRY KU

JERRY KU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12414819
    Abstract: Described herein are systems, devices and methods that enable dynamic modification of the physicochemical properties of a hydrogel during its in vivo formation and delivery by a catheter. In some example embodiments, an extended endoluminal hydrogel delivery device is employed for delivering a hydrogel within a given body cavity, such as within the lumen of a blood vessel. In some example embodiments, a hydrogel precursor, as a non-viscous liquid, is injected through an intravascular catheter and crosslinking of the hydrogel precursor is initiated within a distal region of the catheter. The crosslinking process is controlled, by a control means associated with a distal region of the catheter, to control or modify one or more properties of the hydrogel. The properties may be controlled such that a hydrogel is suitable to embolize the specific target or deliver drugs or other materials beneficial to the site.
    Type: Grant
    Filed: November 1, 2021
    Date of Patent: September 16, 2025
    Assignees: THE UNIVERSITY OF BRITISH COLUMBIA, RYERSON UNIVERSITY, SUNNYBROOK RESEARCH INSTITUTE
    Inventors: Yuta Dobashi, Jerry Ku, Joel Ramjist, Christopher Pasarikovski, Konrad Walus, John Madden, Victor Yang
  • Publication number: 20220133408
    Abstract: Described herein are systems, devices and methods that enable dynamic modification of the physicochemical properties of a hydrogel during its in vivo formation and delivery by a catheter. In some example embodiments, an extended endoluminal hydrogel delivery device is employed for delivering a hydrogel within given body cavity, such as within the lumen of a blood vessels. In some example embodiments, a hydrogel precursor, as a non-viscous liquid, is injected through an intravascular catheter and crosslinking of the hydrogel precursor is initiated within a distal region of the catheter. The crosslinking process is controlled, by a control means associated with a distal region of the catheter, to control or modify one or more properties of the hydrogel. The properties may be controlled such that a hydrogel is suitable to embolize the specific target or deliver drugs or other materials beneficial to the site.
    Type: Application
    Filed: November 1, 2021
    Publication date: May 5, 2022
    Inventors: YUTA DOBASHI, JERRY KU, JOEL RAMJIST, CHRISTOPHER PASARIKOVSKI, KONRAD WALUS, JOHN MADDEN, VICTOR YANG